PRKAG2 Syndrome — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — PRKAG2 syndrome — a glycogen storage cardiomyopathy mimicking HCM, associated with progressive conduction disease, pre-excitation, and risk of heart block
PRKAG2 mutations cause a glycogen storage cardiomyopathy that phenotypically mimics HCM but has distinct features: (1) LVH (from glycogen accumulation, not sarcomeric disarray); (2) pre-excitation (WPW pattern — from glycogen-filled bypass tracts); (3) progressive conduction disease (may require pacing); (4) short PR interval. It is a distinct entity from sarcomeric HCM with different management: mavacamten is not appropriate (not sarcomeric), the natural history includes risk of complete heart block and HF, and ICD considerations follow different criteria. The 2023 ESC Cardiomyopathy Guidelines classify it among metabolic/storage causes of hypertrophic phenotype (phenocopy). Genetic testing is essential for accurate diagnosis and management.
Reference: ESC (2023): Guidelines on Cardiomyopathies